Clinical Trials Logo
  1. Home
  2. Parkinsonian Disorders
  3. NCT00686699

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Parkinsonian Disorders Clinical Trial

Official title:
A Phase 2a, Multiple Dose, Placebo Controlled, Randomized, Two Way Crossover Study to Assess the Efficacy of SCH 420814 in Reducing Anti Psychotic-Induced Extra Pyramidal Symptoms Among Subjects With Schizophrenia and Schizoaffective Disorders

Clinical Trial Summary

This study was designed to determine if preladenant (SCH 420814, MK-3814) can reduce drug-induced involuntary movements in participants with schizophrenia or schizoaffective disorder. Participants were to be evaluated for two 14-day treatment periods with a 3-week washout period between treatment periods. The primary outcome measure, Extrapyramidal Symptom Rating Score (ESRS), was to be evaluated frequently during the treatment periods.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00686699
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Terminated
Phase Phase 2
Start date July 10, 2006
Completion date March 6, 2008
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT00355927 - Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders. N/A
Completed NCT04704349 - Latest Imaging SPECT System Evaluation Phase 1 N/A
Recruiting NCT03649503 - The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
Completed NCT01385592 - Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias Phase 2
Completed NCT05608915 - External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait N/A
Recruiting NCT04871464 - Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease Phase 4
Withdrawn NCT04847609 - GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders
Completed NCT05356845 - Oral Health, Orofacial Function and Oral Health Care in Patients With Parkinson's Disease
Completed NCT02021903 - Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies N/A
Completed NCT03065192 - Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease Phase 1
Not yet recruiting NCT04727658 - Linac FRACtionated Radiosurgical THALamotomie in Tremors (FRACTHAL) Phase 2
Recruiting NCT02696603 - Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower) N/A
Completed NCT01491932 - Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias Phase 2
Recruiting NCT05906719 - Machine Vision Based MDS-UPDRS III Machine Rating
Completed NCT03156647 - Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome
Recruiting NCT02994719 - Gait Analysis in Neurological Disease
Completed NCT04974034 - Movement Disorders Analysis Using a Deep Learning Approach
Completed NCT04925622 - Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
Recruiting NCT06193252 - Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands N/A
Enrolling by invitation NCT06283043 - Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease